Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You nailed it, either it will be home run, or 4 months from now CB will raise money at .11 instead. In 2 months from previous financing he had to raise capital at half of what other's paid 0.45. Based on his track record, I think i will get in @0.11 or 0.05c in near future
Is it only me or others too are seeing Red.
Canada is giving funds for Covid research, so how come Lexaria is not getting $2 mil from HealthCanada and has to raise PP
Look's like Nicotine is aiding in blocking Coronavirus, so vaping might go up, but not Dehydratech...
https://news.yahoo.com/scientists-perplexed-low-rate-coronavirus-170200046.html
Recovery is short termed, you will see it dips back in 20's by end of day.
and back to 0.02 by end of week.
They are loosing 10-15 mil per month looking at the filings from jan 2020 to march 2020. By the time they get any revenue, they would have lost another 60-80 mil in next 5-6 months.
With the pending lawsuits, this will go back to 0.02's in by end of this week.
You are right , he didn't say it , but that's the speculation he is building up by his actions. Out of nowhere the use of Dedhydratech for covid-19 news and partnering with some university. Filing of Patents.
Until now it was all about Altria, TurboCBD, ChrgD+, and now the focus is Covid-19.
My point is simple, do we have any proven or successful initiative of Lexaria and that's where i have doubts about leadership, managements. Since they are paying themselves 300k annual + options worth another 300k each.
Seems to me, you are not liking folks asking keys questions that raise doubt of Bunka's ability to lead an initiative and make it succesfully. From the past failures related to Vipova Tea, Hemp bars, TurboCBD,ChrgD
and now the Nicotine - Altria phase 2 deal, it is difficult to trust him on Covid-19...antiviral stuff.
Something is wrong for sure,I am not able to pin point the root cause though.Is it failed leadership, cause they had awesome vision when Vipova was suppose to reach every household through Walmarts , krogers etc, hemp bars were suppose to reach every fitness centers, gas stations,
And TurboCBD/Chrgd at all every CBD stores and Dispensaries.
And now suddenly focus is that every one will get Covid-19 antiviral shot through Dehydratech and Lexy will receive millions of Dollars for doing research on covid-19 from Health Canada. See how he keeps on changing the target. Until now he never filed patent, but now that there is case to be made, patent got filed to stop stock from sliding further.
Can you ask him about distribution/network for TurboCBD and ChrgD. Seriously,if so many CBD products are available, if the Lexaria can highlight how their product are different and more bio absorable, why aren't they selling more?
Aren't they marketed right?
Bunka could not get Altria to invest another $4 mil for next phase, the company which had invested billions in Cron and Juul.
You think he can get Govt to invest in his Dehyratech?
That's exactly how i had thought that
Vipova Tea will be there in every household,stores,online
Hemp Bars will in every fitness/stores
TurboCBD will be there in every CBD and pharmacy stores
Chgd'D will be bought by anyone who wants to add CBD to their drink's ,be it any ..
The mind does not stop speculating, but all of them turned out to be failures. Bunka is all over the place. Had never focused on one part of expand it.
Right now you are just hoping, that Nicotine thing works out with Altria
Covid-19 Anti viral thing works out with any of fortune 500 companies.
Until that Bunka will keep on getting $300k salary and stock options... worth another $200k
So Reno and Dessert Inn went for $25mil
Decatur for 5.5 (originally it was for 11 mil and it did not go through)
EG for $3 mil
Dyer for 9.2 mil
So what is left , and how much revenue can they generate.
Blum Oakland
Blum San Leandro
Blum Santa Ana (SoCal)
I doubt that, cause 1st qtr there have been lot of hoarding of Cannabis and most of the dispensaries were out of supply. Don't know about TRTC, but other's were running out of supplies
With EG sold / transferred for $3.5 mil , and all these dispensaries pretty much operating in Delivery mode, how many employees they really need.I believe may 10-15 for corporate and 5 employees/dispensary and 8 per cultivation, and lab. That should bring their employee count to less than 100 and provide some cost savings.
If TRTC can reduce SG&A and no longer invest anything until all the 25+11 mil is recovered from the sales for three dispensary, there is some chance that it can turn around the stock with share buy back and strategic investment.
Any thing from OneQor will be additional to this.Until Oneqor releases finances, it is difficult to judge how much it will add to bottom line
It is hard to believe that company that will spent $1.8 bil+ for CRON would think so much to invest $4 mil. Something is fishy.
This is the first time Bunka has set the expectations that if Phase II is not commenced, then they will go with someone else, so it means he is already aware about it.
Can someone explain 300k salary...,without any revenues...
The SGA is 4.5 mil , product dev- 650k , marketing 1 mil. if they reduce workforce by 60% and suspend some of their prod dev and reduce mktg budget, they can still survive for next 6-8 month as they have $972k
The two they have sold for $25 mil, do we know when will they get money for those. They have EG which is like 9 mil and another dispensary for $11 mil to see. if they get those sold , we are looking at cash flow of $45 mil and that will keep it alive for another 2 yrs, as most of the construction is done. Even if they do buy back for $10 mil, this will go past $2/- in two weeks run.
This will test 0.32's in two days and can go all the way to 0.22 and then to 0.14 before it goes back up in next 3 months.
There is no fact's , all futuristic statements and speculation.
No details available on how the Altria or University studies are going through.
looks like u made sure of it, bought to just make it look green.
u have missed the point though. it will correct itself to .30s unless there is change in fundamentals. good luck holding until then
Its already gone back to 0.44's and will close -ve as profit takers will take their profit based on the small run created by "Letter from CEO". This will go back to 0.30's and stay there until the fact's are established. Everything else is just forward looking statements.
Its already gone back to 0.44's and will close -ve as profit takers will take their profit based on the small run created by "Letter from CEO". This will go back to 0.30's and stay there until the fact's are established. Everything else is just forward looking statements.
Even company like CVSI which held more than $4/- for more than yr could not uplist. Their revenue was over $15 mil/qtr. We hare at $70k in revenue, please see the fact's , don't just plain pump based on "Letter from CEO". He has stated nothing new that we already know.
Will close -ve today and back to 0.30's by Mon/Tue.
The letter did help, but those are all forward looking statements, no fact's or revenue no's stated.
Lot of fluff , damage control is what he is upto. Almost everything is forward looking and my only contention point is, if the technology is great and proven, why none of the MSO's are going after them
CEO does not care much, only worried about 300k Salary.
Their product's are not getting sold. All the bio availability, patents, licensing bullshit is not even able to generate 68k in revenue. That speaks for itself how much bluff he is smoking from his ass.
If the technology was that great, why no MSO are seeking it.
Mathew Morgan had successfully lead Reef Dispensaries , Bloom Dispensaries and Tryke industries. His experience in running Blum dispensaries and his connections is the value he is bringing to this merger.
With 31 mil revenue, 36 mil of asset sale left, the mcap is not reflecting true value and PPS is bound to rebound to 0.50's in the near term and to $2+ upon turnaround or relevant news.
For me personally, TRTC should sell Edible gardens as focusing on THC and CBD and partnering with MSO is what will drive it up.
Selling Basil, super lettuce is not lucrative and overhead that they can easily reduce.
Did HRVSF and Verano Holdings LLC (Verano Farms) merger go through.
Do we know what's going on with the $36M asset sales. The one that got cancelled for $10M and is being re-negotiated. If even one go the other two go through, it will give them enough cash to buy back if not $20 mil, but $5 to $10 mil shares and get the PPS to $1 to $1.5
$30M shares
5 mill warrant's - 90% priced at avg of $1.10
Going back to $4.00 by end of this week
Exactly the same thing, why don't we see upswing in sales of all the products - Chgd+ and TurboCBD. If we have scientific proof of how LXRP products delivery method will give quick onset and maximum CBD, why we don't see reflected in the sales.
Why other dispensaries are not carrying those TurboCBD, Chgd+, Poviva Tea, Hemp Bar's in their dispensaries.
Where are marketing and distribution agreements of those with major distributors.
Why none of the LP's are showing interest in proprietory DehydraTech delivery method for manufacturing their own lines of CBD edibles.
That part is clear, giving oneself huge base salary and stop options is.
You are clearly speculating and not looking at the failed product launches
Poviva Tea/Cofee
Hemp Bar
TurboCBD
Chrd'D
The stock price came down from 1:50 to 0.45 with money wasted in producing those.
The only +ve thing they have is with Altria, and that too we have no updates.
When it comes to transparency this CEO sucks.
By now Altria should have invested additional million's that they had agreed on for milestone achievements in R&D Process. Since additional $ not invested, i believe the milestones have been been achieved.
Ok, just like Poviva Tea and Hemp Protein bar's being available in all the fitness centers across 50 states, looks like TurboCBD and ChrgD+ , both have fizzled.
Why would someone just not buy those sachet's and add them to any drink to make it Hemp drink?
Am i missing something.
I fail to understand how come Altria was ok with investing 12.8B in JUIL and 1.8B in CRON, but has not given another couple of million beyond the initial 1M to Lexaria.
If everything was going fine, and its been more than 10 months since the agreement was announced, by now they would have found some +ve results for Altria to invest more than 1M.
So is everything really going right in R&D?
Thanks
Jatin Rajdeo
So many things going on ,but not able to generate Revenue
TurboCBD - Revenue?
ChrgD+ - Revenue?
Licensing - Hardly any revenue ?
This company is unable to generate revenue and the CEO keep's on paying himself 300k salary and selling shares.
Has created 4 subsidiaries, but nothing is happening in any of those.
Vape crisis should have increased LXRP share's , but instead they too lost 70% in past 3 months.
Am thinking of selling and buying one of the MSO's for 5x-10x returns instead.
What were the terms of settlement with Van Verde.
Do we know the terms of settlement for Van Verde?
Are they getting any money out of it.
Are they buying using that money or are pocketing all that for personal gains?
Do we know the terms of Settlement with Van Verde. They have not released if TRTC gained anything or all the money received went in their own pockets
Do we have any update on the lawsuit
Its not about quantity ingested, but rather how soon you feel relief from the pain. Folks here would agree that if something is going to give you faster pain relief, then you would prefer that over some other medication that will take 1 to 2 hrs after ingesting.
That's why people prefer Allopathy over Homeopathy / Naturopathy sometimes to get quick results.
CBD is going to give pain relief, not get rid of pain until underlying issues are addressed.
There are some pains which are Chronic and you can never get rid of pain, but just rather get rid of symptoms. So in such cases LXRP products are well suited.
IMHO, LXRP has ground breaking technology and as soon as any of Big Pharma's or Big LP lay's eyes on its technology, this will fly to $5 to $10 and in a year or two to $20 to $50
The result is not bad, they improved a lot on Gross Margin and their burn rate went down.
I would have liked it even if they would have done $9 to $10 mil 1st Qtr, that would have shown that the company has started make strides, but nevertheless, its a slow start, but surely, its a START...to recovery.
If they continue to build on this and increase their momentum by 50%, i can see they can easily meet their revenue targets.
I believe DP is executing on the planned objectives, infact he has exceeded it , instead of 45 it is 54%
Below outlines the goals and objectives the Company has set for itself in 2019:
Increase Gross Margin to 45%
Meaningful EBITDA improvement
Achieve a $63.3 Million revenue run rate within Q4 2019
Cease accessing the capital markets by the end of the first half of 2019 to fund CapEx and OpEx
Streamlining operations and headcount to mitigate operational burn
Enhance corporate governance
Better stockholder communication as management achieves milestones
Launch Branded Delivery
Establish a Pop-Up Retail experience